Summary Human hHbl beings to the type 11 hard keratin family and is physiologically expressed in hair shafts. In the present study, using specific 3' and 5' probes for hHbl, we established that breast carcinomas ectopically express a hHbl 5'-truncated mRNA, and that this transcript is restricted to malignant epithelial cells. Furthernore, an in vitro study indicated that it could be twanslated. We concluded that, in breast carcinomas, expression of truncated hHbl is related to epithial cell transformation. Because the hHbl gene maps to 12q11-q13, a chromosome region known to present several breakpoints in solid tumours, we propose that the hHbl gene might represent a target for such alterations.
By differential screening of a cDNA library established from metastatic lymph nodes derived from a human breast cancer. we have previously identified and cloned the MLN 137 cDNA (Tomasetto et al. 1995 ) (accession no. X80197). This cDNA is 1124 nucleotides long and shows homologies with sheep wool keratin K2-9 (Powell et al, 1992) . At the same time, Rogers and co-workers cloned the human hHbl cDNA counterpart of K2-9 (Rogers et al. 1995) . The gene coding for hHbl has been mapped to the type H keratin cluster at 12q 1-q13 (Rogers et al, 1995) . Comparison of MLN137 and hHbl sequences showed that MLN 137 corresponds to the 3' half of the hHbl cDNA. In situ hybridization to human scalp showed strong hHbl expression in the cortical cells of the hair shaft. from the lower cortex. slightly above the apex of the dermal papilla. to the upper third of the cortex (Regnier et al. 1997; Rogers et al. 1997) . Furthermore, hHbl expression was also observed in the transitional cell layer in pilomatricoma, a tumour exhibiting follicular differentiation (Regnier et al. 1997) .
Keratins belong to a multigene family which contains more than 30 members. They are grouped into type I acidic and type H basic to neutral proteins. The association of equimolar amounts of distinct pairs of type I and type H keratins gives rise to intermediate filaments which are organized in networks in epithelial cells (Bloemendal and Pieper. 1989) . Most keratins correspond to soft a-keratins, expressed in various types of epithelia, whereas hard a-keratins are involved in the formation of hair and nails. The hair keratin family is composed of four major type I (Hal-4) and type II keratins. and a minor pair (Hax and Hbx) (Heid et al, 1988) . Recently. several other members have been reported for type I and type H hair keratins. showing that these families are more complex than previously assumed (Rogers et al. 1997 Cedex, 67404, France Little is known about the precise mechanisms underlying the regulation of the hair-specific keratins. In addition to recognizing motifs used by many eukaryotic genes in transcription. such as API, AP2 and SPI sites. a number of potential regulatory motifs have been identified. Two of them, referred to as the HK-1 (Rogers and Powell, 1993) and LEF-1 (Zhou et al. 1995) motifs. have been shown to be able to regulate tissue-specific expression of keratins. Furthermore, because keratins form a gene cluster. their expression could, at least partially. be regulated by a locus activation region.
In normal human breast tissue. immunohistochemical analysis showed that the basal and luminal cells of the ducts can be discriminated by the keratins they express. K5 and K14 are specific to myoepithelial cells, whereas luminal cells are characterized by expression of K7, K8. K18 and K19. Several soft keratins are produced in breast carcinomas. and they are used as tumour markers because their profile of expression correlates with different types of epithelial differentiation and function (Trask et al. 1990; Nathrath and Lane. 1994) . They can be found intratumourally and in the blood. circulating as partially degraded complexes. High levels of K8. K18 and K19 in breast carcinomas have been correlated with a better prognosis. whereas a decrease of K5 was associated with tumour progression (Trask et al. 1990: Nathrath and Lane. 1994) .
Here. we have studied the expression of hHbl in benign and malignant breast tumours by Northern blot analysis using 3' and 5' probes specific for hHbl .
MATERIALS AND METHODS Human cell lines and tissues
Breast cancer cell lines are described and are available im the American Type Culture Collection (ATCC. Rockville. MD. USA). Cells were routinely cultured in Dulbecco's modified Eagle medium supplemented with 10% fetal calf serum.
hHbl amino-truncated hair keratin expression 1641 RNA preparation and analysis RNA preparation and anailysis w~ere performed as previously reported (Tomasetto et al. 1995 
RESULTS
Nor2th blot analysis of benign and malignant breast tumours using a hHbl 3' probe Keratin structure can be subdivided into three parts. There is a centrl rod occurring in a helical conformation, interrupted by three short non-helical linkers whose length and sequence are well conserved in all kerains. This core structure is flanked by anino-(N-) and carboxy-(C-) terminal non-helical regions, the head and tail domains, respectively, which are specific to each keratin (Bloemendal and Pieper, 1989) (Figure IA) . MLN137 cDNA which encodes half of the helical domain, the tail domain and the 3' untranslated region (UTR) of hHbl ( Figure IA and B (Figure 2, lane 7) . Breast fibroadenomas (15 cases studied) as well as normal adult lung, stomach, colon, liver, kidney and placenta were negative (Figure 2 , lanes 9-11, and data not shown).
On Northern blots, the transcript detected using the hHbl 3' probe exhibited a size of 1.1 kb. This size was not in accordance with that of about 2 kb deduced from the full-length hHbl cDNA (Rogers et al, 1995) . However, it fits with that of the MLN137 cDNA (1124 bp) cloned from a breast cancer metastasis, suggesting that breast carcinomas express a 5'-truncated form of hHbl mRNA.
Cloning of the hHbl 5' probe To test this hypothesis, we cloned the full-length hHbl cDNA and designed a hHbl 5' specific probe. Using in situ hybridization, we had previously observed that the hHbl 3' riboprobe hybridized to a tanscipt present in hair shafts (Regnier et al, 1997) . We assumed that, at this physiological site of expression, the transcript detected should correspond to the complete hHbl mRNA. Thus, we constructed a scalp cDNA library (see Materials and methods). Its screening, using the MLN137 probe, led to the identification and cloning of a full-length hHbl cDNA. A 327-bp fragment of the 5' end of this cDNA corresponding to the 5' UTR and part of the head of hHbl was subcloned to produce a hHbl 5' specific probe ( Figure IA Bright field (A and B) Breast carcinomas expressed a hHbl 5'-truncated mRNA 3' and 5' hHbI probes were used for Nortern blot analysis of RNA samples extracted from the SK-BR-3 breast cancer cell line. and from normal breast skin and scalp (Figure 3 ). Whereas the hHbl 3'probe hybridized to transcripts of 1.1 kb and 1.9 kb in SK-BR-3 and scalp, respectively, the hHbl 5' probe only detected the 1.9-kb mRNA in scalp. As expected. normal breast skin was devoid of the 1.1-kb and 1.9-kb transcripts. Moreover, using the hHbl 5' probe. none of the nornal and malignant tissue samples previously tested with the hHbl 3' probe ( Figure 2 ) gave positive signals. Together. these findings showed that the 1.1-kb mRNA.
detected in breast carcinomas with the hHbl 3' probe, but not with the hHbl 5' probe, corresponds to a 5'-truncated form of the 1.9-kb hHb I mRNA normally expressed in hairy skin. Using a hHbl 3' riboprobe. in situ hybridization showed that the hHbl 5'-truncated mRNA was specifically expressed by malignant epithelial cells in both primary and secondary tumours (Figure 4) . The stromal compartment of the tumours as well as normal ducts were negative. These results indicate that the ectopic expression of hHb1 5'-truncated mRNA is related to the malignant status of mammary epithelial cells.
In vitro translation of the hHbl 5'-truncated (MILN137) Figure 1B) . Moreover, two potential sites of initiation of translation were present. giving nrse to putative proteins corresponding to either the last 202 or 235 amino acids of the C-terminal part of the hHbl keratin. To determine whether these sites are functional, we performed in vitro translation of the MLN137 mRNA. Sense NMLN137 RNA gave rise to a band of 27 kDa. whereas no band was observed using MLN137 antisense RNA as control ( Figure 5) . A protein size of 27 kDa is consistent with a 235-amino acid long protein. Accordingly. the first ATG codon had the most favourable context for initiation of translation (Kozak, 1996) . Thus, the MLN137 mRNA corresponding to the 5'-truncated fonn of hHbl mRNA is translated in vitro. suggesting that a N-truncated hHbl keratin could be synthesized in vivo in some breast carcinomas. (Tomasetto et al. 1995) corresponding to the 3' end of the hHbl hair keratin cDNA (Rogers et al. 1995) .
In the present study, using two probes specific to the 5' and 3' ends of the hHbl cDNA. we established that breast carcinomas specifically express a 1.1-kb 5'-truncated form of the hHbl mRNA. In addition, an in vitro translation study showed that a N-truncated hHbl protein can be translated. The hHbl 5'-truncated mRNA was not present in the hair shaft which expresses the wild-type 1. (Bloemendal and Pieper, 1989; Rogers et al, 1997) . Abberent forms of soft keratin have been shown to be responsible for several epidermal genetic diseases. notably through the formation of dominant negative heterodimers (Fuchs and Coulombe. 1992; Compton. 1994) . In breast carcinomas, profiles of soft keratin expression are used as tumour markers to discrinminate various subtypes of tumours. because they correlate with different statuses of epithelial cell differentiation (Trask et al. 1990; Nathrath and Lane, 1994) . Finally, aberrant expression of the soft keratin K13. normally associated with the terminal differentiation of internal stratified epithelia. has been reported in mouse skin tumours (Nischt et al. 1988 ).
Very little is known concerning pathological expression of hard keratins (Smack et al. 1994 an extremely heterogeneous disease (Lonn et al. 1994) . and hHbl 5'-truncated mRNA might permit the discrimination between particular subtypes of breast cancer. Further clinical studies are now required to determine the diagnostic and/or prognostic value of the expression of truncated hHb 1. S'-truncated forms of mRNA could result from gene alterations occurring during cell transformation, such as partial gene deletion or gene mutation(s) leading to altered splicing. Another possibility is that the hHbl '-truncated mRNA results from gene translocation. as previously reported for the PML to RAR-a translocation in myeloid and lymphoid leukaemias for example (Sawyers. 1997) . In this context we note that the hHbl gene maps to the 12q1 l-q 13 band of the human genome (Rogers et al. 1995) . a region already known to be involved in chromosome translocation in a wide variety of solid tumours. notably breast carcinomas (Van de Ven et al, 1995) . Thus. it is tempting to speculate that gene translocation leading to aberrant genes containing the 3' coding region of hHbl fused to the regulatory sequences of another gene could be responsible for the expression of the truncated hHbl. In this case, it will be of interest to determine the nature of this gene specifically upregulated in breast carcinomas. Sequencing of upstream regulatory regions of the corresponding genomic DNA extracted from breast carcinomas and FISH experiments performed on breast cancer cells will enable us to test this attractive hypothesis.
